
Background and Objectives of the Contest
The contest is part of Johnson & Johnson's Smart Healthy Aging Initiative (SHAI), an initiative aimed at extending healthy life expectancy and improving the quality of life (QOL) of the elderly.
In the age of 100 years of life, the realization of a "Smart Healthy Aging" society in which each individual can lead a healthy and fulfilling daily life for a long time is a major challenge. This contest seeks innovation ideas in the following five areas to help realize this goal: (1) Vision (ophthalmology), (2) Oncology (oncology), (3) Orthopedics (including osteoarthritis), (4) Digital surgery, and (5) Cerebrovascular diseases.
Johnson & Johnson is taking the Quickfire Challenge on a global level.
By 2050, one in four people in the Asia-Pacific region will be 60 or older, and the elderly population is expected to triple between 2010 and 2050 to approximately 1.3 billion*1.
In Japan*2, a country with one of the world's longest life expectancies, the elderly population aged 65 and over already accounts for nearly 30% of the total population*3.
However, there is an approximately 10-year gap between average life expectancy and healthy life expectancy in Japan*4, and approximately 631 TP3T of the elderly over 65 years old are said to be "multimorbid" with multiple chronic diseases*5.
It has been reported that multiple morbidities are linked to a decline in physical function and quality of life, as well as to an increase in mortality rates. *6 With social security costs expected to rise further in the future due to the increase in the number of elderly people suffering from multiple chronic diseases*7, extending people's healthy life expectancy is a major social issue.
In response to this situation, Johnson & Johnson, with its expertise in medical devices (including ophthalmic medical devices), ethical drugs, and consumer goods, is promoting efforts to realize a "Smart, Healthy Aging" society through industry-government-academia collaboration.
As part of this effort, the contest seeks a wide range of ideas that contribute to extending healthy life expectancy.
The winning team of this competition will receive a grant from Johnson & Johnson totaling up to $300,000.
You will also receive virtual access to the Johnson & Johnson Innovation - JLABS Asia Pacific community, including a dedicated desk at JLABS@Shanghai, Johnson & Johnson's incubation lab for one year, and access to Johnson & mentorship by Johnson & Johnson experts is also available.
Johnson & Johnson aims to contribute to the global challenge of extending healthy life expectancy by using SHAI and the innovations generated through this competition as a model case study.
Japan Smart Healthy Aging QuickFire Challenge Overview
Application period: Wednesday, September 14, 2022 - Friday, December 2, 2022
Award announcement: March 2023 (official date to be determined at a later date)
Organized by Johnson & Johnson Innovation
Cooperation: Johnson & Johnson K.K. (Medical Company and Vision Care Company), AMO Japan K.K., Janssen Pharma K.K.
Target areas: (1) Vision (ophthalmology) (2) Oncology (oncology) (3) Orthopedics (including osteoarthritis) (4) Digital surgery (5) Cerebrovascular diseases
Format and selection method: Document review and presentation to internal and external judges
Eligibility: Anyone can apply.
How to participate: Please complete the form by Friday, December 2, 2022.
Click here to apply: https://jnjquickfire.secure-platform.com/a/solicitations/67/home
About the Quickfire Challenge (in English): https://jnjinnovation.com/innovation-challenges/japan-smart-healthy-aging-quickfire-challenge
About the Quickfire Challenge (Japanese): https://www.jnj.co.jp/story-innovation/quickfire-challenge-2022
About Johnson & Johnson Japan Group
It consists of Johnson & Johnson K.K. (Consumer Company, Medical Company, Vision Care Company), Janssen Pharma K.K., AMO Japan K.K., and others.
About Smart Health Aging Initiative (SHAI)
The healthcare challenges associated with the global aging of the population are also a major opportunity. In Japan, an advanced aging society, the population over the age of 65 is approaching 30% of the total population and still expanding. Despite Japan's long average life expectancy, there is a gap of about 10 years between healthy life expectancy and average life expectancy (the "lost decade") due to declining quality of life (QOL) in old age.
To help shorten this lost decade, Johnson & Johnson Japan has launched the "Smart Healthy Aging Initiative (SHAI)" to address the needs of both healthy elderly people and elderly patients by bringing together its technological capabilities and knowledge as a total healthcare company handling consumer products, medical devices, and ethical drugs. The Smart Healthy Aging Initiative (SHAI) was launched to address the needs of both healthy elderly people and elderly patients.
To improve the quality of life of the elderly, SHAI is working to generate insights and develop solutions in multiple disease areas through partnerships and collaborations with external partners, including leading universities, research hospitals, private companies, and data providers, as well as to build a broad ecosystem.
For more information about SHAI, click here. https://www.jnj.co.jp/smart-healthy-aging
About Johnson & Johnson
Johnson & Johnson believes that health is the foundation of a fulfilling life, the prosperity of communities, and the driving force behind progress. Based on this belief, we have supported the health of people of all ages and at all stages of life for more than 130 years.
Today, we strive to maximize our strength as one of the world's largest and most extensively located healthcare companies to create a healthier society where everyone, everywhere, can enjoy physical and mental health and a healthy environment, with access to healthcare at a fair price.
Johnson & Johnson is working to dramatically advance healthcare by combining our spirit, the power of science, and groundbreaking ideas.
[Source.
*1 United Nations Population Fund HP https://asiapacific.unfpa.org/en/topics/ageing-6
*2 Statistical Handbook of Japan2021, Statistics Bureau, Ministry of Financehttps://www.stat.go.jp/english/data/handbook/c0117.html
*3 Statistical Handbook of Japan2021, Statistics Bureau, Ministry of Financehttps://www.stat.go.jp/english/data/handbook/c0117.html
*4 Ministry of Health, Labour and Welfare, "Healthy life expectancy in 2028.https://www.mhlw.go.jp/content/10904750/000872952.pdf
*5 Physical multimorbidity patterns and depressive symptoms: a nationwide cross-sectional study in Japan
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032897/#:~:text=A%20study%20that%20was%20conducted,those%20aged%2065%20or%20older.
*6 The associations of multimorbidity with the sum of annual medical and long-term care expenditures in Japan
indecentttps://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-019-1057- 7#:~:text=and%20LTC%20systems.-,The%20occurrence%20of%20multimorbidity%20(i.e.%2C%20the%20coexistence%20of%20multiple%20chronic,even%20higher%20mortality%20%5B6%5D.
*7 Japan Health Policy NOW http://japanhpn.org/en/demographic/









